menu
    • menu

    Company profile for Phoenix Pharmalabs

    NEW Drugs in Dev: 1
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Phoenix PharmaLabs, Inc. (PPL) is a privately held preclinical drug discovery company focusing on the development and commercialization of new non-addictive treatments for pain and new therapies for the treatment of opiate addiction. PPL was founded in 2002 with the mission of bringing its new class of opioid pain therapies and addiction treatment to market. PPL has designed a novel family of ligands with high binding affinit...
    Phoenix PharmaLabs, Inc. (PPL) is a privately held preclinical drug discovery company focusing on the development and commercialization of new non-addictive treatments for pain and new therapies for the treatment of opiate addiction. PPL was founded in 2002 with the mission of bringing its new class of opioid pain therapies and addiction treatment to market. PPL has designed a novel family of ligands with high binding affinity at all three opiate receptors: mu, kappa and delta.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Phoenix PharmalabsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Phoenix PharmaLabs, Inc. 999 West 1500 South #600 Woodscross, UT 84087
    Telephone
    Telephone
    +435-881-5820
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://phoenixpharmalabs.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/phoenix-pharmalabs-inc-/?originalSubdomain=in
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BePharma

    Not Confirmed

    envelop Contact Supplier

    BePharma

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Phoenix PharmaLabs’ Lead Compound, PPL-138, Offers Promise as PTSD/AUD Treatment
    Phoenix PharmaLabs’ Lead Compound, PPL-138, Offers Promise as PTSD/AUD Treatment

    14 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230914705291/en

    BUSINESSWIRE
    14 Sep 2023
    Share Share
    Phoenix Awarded $8.7 Million Grant from NIDA to Study Compound
    Phoenix Awarded $8.7 Million Grant from NIDA to Study Compound

    06 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221006005212/en

    BUSINESSWIRE
    06 Oct 2022
    Share Share
    Phoenix Successfully Completes Second Oversubscribed Netcapital Offering Raising
    Phoenix Successfully Completes Second Oversubscribed Netcapital Offering Raising

    22 Jun 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210623005592/en

    BUSINESSWIRE
    22 Jun 2021
    Share Share
    Phoenix Strengthens its Position as a Developer of Next Generation Pain Pharma
    Phoenix Strengthens its Position as a Developer of Next Generation Pain Pharma

    05 Jan 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210105005158/en/Phoenix-PharmaLabs-Strengthens-its-Position-as-a-Developer-of-Next-Generation-Pain-Pharmaceuticals-with-the-Acquisition-of-a-Portfolio-of-NOPMu-Agonist-Compounds

    BUSINESSWIRE
    05 Jan 2021
    Share Share
    Phoenix PharmaLabs Announces New Investment Offering with Netcapital
    Phoenix PharmaLabs Announces New Investment Offering with Netcapital

    21 Dec 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20201221005188/en/Phoenix-PharmaLabs-Announces-New-Investment-Offering-with-Netcapital

    BUSINESSWIRE
    21 Dec 2020
    Share Share
    BridgeBio Pharma’s Phoenix Tissue Repair Provides Updates t RDEB
    BridgeBio Pharma’s Phoenix Tissue Repair Provides Updates t RDEB

    13 May 2020

    // GLOBENEWSWIRE

    http://www.globenewswire.com/news-release/2020/05/13/2032992/0/en/BridgeBio-Pharma-s-Phoenix-Tissue-Repair-Provides-Updates-to-its-Recessive-Dystrophic-Epidermolysis-Bullosa-RDEB-Program-and-Announces-New-Leadership-Appointments.html

    GLOBENEWSWIRE
    13 May 2020
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search